HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
✍ Scribed by Francoise Brun-Vezinet; Charles Boucher; Clive Loveday; Diane Descamps; Veronique Fauveau; Jacques Izopet; Don Jeffries; Steve Kaye; Corinne Krzyanowski; Andrew Nunn; Rob Schuurman; Jean-Marie Seigneurin; Catherine Tamalet; Richard Tedder; Jonathan Weber; Gerrit-Jan Weverling
- Book ID
- 118562279
- Publisher
- The Lancet
- Year
- 1997
- Tongue
- English
- Weight
- 105 KB
- Volume
- 350
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In Southernmost Brazil HIV‐1 subtypes B, C, and CRF31\_BC co‐circulates and, since 1996 with the implementation of free access to highly active antiretroviral treatment (HAART), this epidemic is under a quite characteristic selective pressure. The profile of mutations and polymorphisms
## Abstract Therapy failure due to drug resistance development is a common phenomenon in HIV‐infected patients. However, when the drug pressure leads to the earliest selection of drug‐resistant HIV‐1 populations is still unclear. In this study, the extent to which selection of the HIV‐1 reverse tra